Navigation Links
New European collaboration on cancer research
Date:1/19/2011

Europe's leading oncology organisations are combining forces in the global fight against cancer. The project, EurocanPlatform, has received 12 million from the European Union to streamline cross border research. The project will find more effective ways to ensure the prevention, early discovery and treatment of different forms of cancer.

Professor Ulrik Ringborg from the Swedish medical university Karolinska Institutet, who is coordinating the project, comments, "In a way, you could say that this initiative represents a paradigm shift in cancer research. The project will last for five years, establishing a collaborative structure within the EU for cancer research."

Despite improved diagnostics and treatment in recent years, the number of people dying of cancer is expected to rise. Already the world's deadliest disease group, cancer is growing as one of the largest chronic diseases, putting immense pressure on healthcare systems around the globe.

At the same time, however, modern cancer research is rapidly improving understanding of the disease, and new technologies are being developed for use in patient focused cancer research. Scientists hope that they will one day not only be able to identify people at risk for cancer, but also adapt therapies to different types of cancer and to patients' individual circumstances.

"An important part of the project involves getting the right therapy to the right patient at the right time," says Professor Ringborg. "But before we can get there, we need to do a great deal of research since the range of possible tumours and therapies is vast. No one research centre can have the resources needed. We must make sure that we coordinate and exploit the resources we have to the full."

EurocanPlatform is a network of Europe's 28 most research-intensive institutions in the field of cancer, of which the majority are clinical (patient focused), the remainder being engaged in basic research. A great many researchers from Sweden, Denmark, Norway, France, Spain, Italy, Germany, Hungary, the Netherlands, Belgium, and Britain are involved in various parts of the project. The collaborative platform allows individual research groups and organisations to conduct studies they would not otherwise have the resources for; with the costs of expensive equipment, tumour material and competence shared.

"The ultimate winners will be the patients, the public and the healthcare services." adds Professor Ringborg.

EurocanPlatform is due to hold its first conference in Stockholm on 20 January 2011. The project has gained funding under the EU's Seventh Framework Programme and is classed as a Network of Excellence (NoE).

Below is a list of the EurocanPlatform partners:

  1. Karolinska Institutet ("Coordinator"), Sweden
  2. Institut Curie, France
  3. Danish Cancer Society, Denmark
  4. Oslo Comprehensive Cancer Centre, Norway
  5. Spanish National Cancer Centre, Spain
  6. Istituto Nazionale dei Tumori, Italy
  7. German Cancer Research Centre, Germany
  8. Institut Gustave Roussy, France
  9. International Agency for Research on Cancer, France
  10. University of Oxford, UK
  11. European Institute of Oncology, Italy
  12. Christie NHS Foundation Trust, UK
  13. National Institute of Oncology, Hungary
  14. Netherlands Cancer Institute, Netherlands
  15. Erasmus Medical Centre, Netherlands
  16. Cambridge Cancer Research Institute, UK
  17. Institut Jules Bordet, Belgium
  18. European Molecular Biology Laboratory, Germany
  19. Institute of Cancer Research, Royal Marsden Hospital, UK
  20. Leiden University Medical Centre, Netherlands
  21. Fundacion Instituto Valenciano de Oncologia, Spain
  22. Istituto Tumori Bari, Italy
  23. Fundacio Privada Institut d'Investigacio Oncologica de Vall Hebron, Spain
  24. eCancer.eu, Switzerland
  25. ECCO The European CanCer Organisation, Belgium
  26. Organisation of European Cancer Institutes, Belgium
  27. European Cancer Patient Coalition, Netherlands
  28. European Organisation for Research and Treatment of Cancer, Belgium


'/>"/>

Contact: KI Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet
Source:Eurekalert

Related medicine news :

1. European Research Council awards advanced researcher grant to KIT botanist Holger Puchta
2. European Multidisciplinary Conference in Thoracic Oncology
3. Chronic Disease Alliance receives European Health Award 2010
4. European Nurse Society calls to action on breakthrough cancer pain
5. Heart, kidney, diabetes and cancer MEP groups league against chronic disease to seek European commitment
6. European Researchers Find Genes Tied to Asthma
7. European partnership funds research toward robot aides for the elderly
8. New case series section in European Urology
9. European Society of Cardiology launches heart-friendly cookery book
10. New impact factor of European Urology underlines journals outstanding position
11. European patient survey add weight to expert call for greater clinical consensus on BTCP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: ... networking and recognition opportunities as well as advocacy for the state and region‘s ... on February 23. The Council's Innovation Forecast event highlights innovation throughout the ...
(Date:2/24/2017)... ... , ... With millions of Americans and people worldwide struggling ... are aware of our options and are empowered with strength and information throughout ... its newest edition of "Vision and Hearing" in USA Today, that will educate ...
(Date:2/24/2017)... , ... February 24, 2017 , ... Yisrayl Hawkins, Pastor ... on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement when ... generation. He explains that the Bible details the current times so plainly that ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to ... Elite division on February 12th. Ms. Esparza qualified into this prestigious status ... competition held in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... the La Gorce Country Club in Miami Beach to host its Swirl: Miami ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)... CITY, Calif., Feb. 23, 2017 Nevro Corp. (NYSE: ... evidence-based solutions for the treatment of chronic pain, today reported ... December 31, 2016. 2016 Accomplishment & Highlights: ... full year 2016, an increase of 228% as reported, over ... for 2016, an increase of 612% over the prior year ...
Breaking Medicine Technology: